Evidence map›Paper›PMID 28326339›Full record

ArticleBone reports2016

Glucose-dependent insulinotropic polypeptide (

Gaurav Garg, Fiona E McGuigan, Jitender Kumar, Holger Luthman, Valeriya Lyssenko, Kristina Akesson

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bone reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Incretin-based therapy: a new horizon in diabetes management.Journal of diabetes and metabolic disorders · 2024
    Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Gaurav GargClinical and Molecular Osteoporosis Research Unit, Dept. of Clinical Science Malmö, Lund University; Dept of Orthopaedics, Skåne University Hospital Malmö, Sweden.
Fiona E McGuiganClinical and Molecular Osteoporosis Research Unit, Dept. of Clinical Science Malmö, Lund University; Dept of Orthopaedics, Skåne University Hospital Malmö, Sweden.
Jitender KumarDept of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Holger LuthmanMedical Genetics Unit, Dept. of Clinical Sciences Malmö, Lund University, Sweden.
Valeriya LyssenkoDept of Clinical Sciences, Diabetes and Endocrinology, CRC, Lund University, Lund, Sweden; Steno Diabetes Center, Gentofte, Denmark.
Kristina AkessonClinical and Molecular Osteoporosis Research Unit, Dept. of Clinical Science Malmö, Lund University; Dept of Orthopaedics, Skåne University Hospital Malmö, Sweden.
Lund University · SESkåne University Hospital · SEUppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe gastro-intestinal hormone glucose-dependent insulinotropic polypeptide (GIP) potentiates glucose-induced insulin secretion, with bone anabolic effects through GIP receptor (GIPR) in animal models. We explore its potential in humans by analyzing association between polymorphisms (SNPs) in the

methodsAssociation between

resultsThe

conclusionsThis first exploratory association study between polymorphisms in

Indexed as

BMDFat massGIPGIPRPolymorphismSerum GIP

Identifiers

PMID28326339
PMCPMC4926814
OpenAlexW2212421950

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.